Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 11, 2007

Debiopharm Receives cGMP Certification for QC of Drug Products

  • Debiopharm achieved cGMP certification from Swissmedic for the chemical, physical, and biochemical quality control work conducted at its laboratory in Gland, Switzerland. Debiopharm now has the alternative to handle its analytical development, formulation, and quality control activities in-house when necessary, according to Kamel Besseghir, CEO.

    Debiopharm also has a cGMP development and production facility in Martigny, Switzerland, which has been inspected by the FDA and Swissmedic. The company reports that it can produce pilot batches of cGMP drug products for feasibility studies, clinical trial supplies, and commercial-scale manufacturing.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »